12 completed, 1 recruiting. 13 Phase 3, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 13 | Completed 12, Recruiting 1 |
| Phase 2 | 2 | Completed 2 |
Follow Tin Fluorides: new trials by email Literature Review of Tin Fluorides trials Research Report on Tin Fluorides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice Stannous fluoride and Potassium nitrate Dentifrice, Stannous fluoride Dentifrice, Potassium nitrate Dentifrice - Dentin Hypersensitivity | Phase 3 | Completed | HALEON | 688 | 2025-09-16 | 2026-08-25 |
| Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC Experimental drug, Control Rx - Metastatic Microsatellite-stable Colorectal Cancer | Phase 3 | Recruiting | Sun Yat-sen University | 176 | 2023-03-01 | 2023-03-14 |
| A Clinical Study Conducted in the Bangkok, Thailand Area, to Investigate the Clinical Efficacy of a New Toothpaste 0.454% stannous fluoride, 0.76% sodium monofluorophosphate - Oral Malodor | Phase 3 | Completed | Colgate Palmolive | 80 | 2017-12-21 | 2025-10-31 |
| Efficacy of Toothpaste Containing 0.454% Stannous Fluoride as Compared to a Regular Fluoride Toothpaste Containing 0.76% Sodium Monofluorophosphate in Controlling Supragingival Calculus Formation Over a 12-week Period. 0.454% stannous fluoride, 0.76% sodium monofluorophosphate - Calculus, Dental | Phase 2 / Phase 3 | Completed | Colgate Palmolive | 100 | 2017-05-17 | 2025-12-11 |
| Investigating the Efficacy of an Occluding Dentifrice in Providing Relief From Dentinal Hypersensitivity stannous fluoride, sodium monofluorophosphate - Dentin Sensitivity | Phase 3 | Completed | GlaxoSmithKline | 242 | 2016-03-01 | 2017-05-25 |
| A Phase 3 Clinical Study Investigating the Gingivitis Efficacy of a Test Dentifrice Containing Stannous Fluoride Stannous fluoride, Sodium monofluorophosphate - Gingivitis | Phase 3 | Completed | GlaxoSmithKline | 98 | 2013-05-28 | 2020-01-31 |
| Investigating the Efficacy of a Dentifrice in Providing Long Term Relief From Dentinal Hypersensitivity Stannous fluoride, Sodium monofluorophosphate - Dentine Hypersensitivity | Phase 3 | Completed | GlaxoSmithKline | 119 | 2013-02-01 | 2015-01-26 |
| Clinical Efficacy of a Toothpaste in Providing Relief From the Pain of Dentinal Hypersensitivity Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity | Phase 3 | Completed | GlaxoSmithKline | 113 | 2012-04-01 | 2014-06-03 |
| The Efficacy of a Dentifrice in Providing Relief From Immediate and Short Term Relief From Dentinal Hypersensitivity Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity | Phase 3 | Completed | GlaxoSmithKline | 120 | 2012-03-01 | 2018-03-06 |
| The Efficacy of a Dentifrice in Providing Relief From the Pain of Dentinal Hypersensitivity Stannous Fluoride, Sodium Monofluorophosphate - Dentine Hypersensitivity | Phase 3 | Completed | GlaxoSmithKline | 120 | 2012-03-01 | 2014-03-10 |
| Donor Simvastatin Treatment in Organ Transplantation Simvastatin 80mg, Control Rx - Heart Failure, Respiratory Failure | Phase 2 / Phase 3 | Completed | Helsinki University Central Hospital | 84 | 2010-06-01 | 2017-09-19 |
| Investigate Oral Bacteria in Adult Population Fluoride, Fluoride, Triclosan, Stannous Fluoride - Oral Bacteria | Phase 3 | Completed | Colgate Palmolive | 24 | 2008-05-01 | 2011-03-23 |
| Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B Water 2mL PO 2 minutes prior to intra-muscular injection, skin-to-skin contact, Glucose 25% 2 mL PO 2 minutes prior to injection - Pain, Analgesia | Phase 3 | Completed | Federal University of São Paulo | 640 | 2006-03-01 | 2008-07-14 |
Dentin Sensitivity (6) · Agnosia (1) · Colorectal Neoplasms (1) · Dental Calculus (1) · Gingivitis (1) · Heart Failure (1) · Liver Failure (1) · Pain (1) · Rejection, Psychology (1) · Renal Insufficiency (1) · Reperfusion Injury (1) · Respiratory Insufficiency (1)
GlaxoSmithKline (6) · Colgate Palmolive (3) · Federal University of São Paulo (1) · HALEON (1) · Helsinki University Central Hospital (1) · Sun Yat-sen University (1)
United States (7) · Thailand (2) · China (1) · Finland (1) · Ireland (1)
Aurimery G Chermont (1) · Daniel Fine, DDS (1) · Dutmanee Seriwatanachai (1) · Jeffery L Milleman (1) · John T Gallob (1) · Karl B Lemstrom, MD, PhD (1) · Pejmon Amini (1) · Ruihua Xu, MD (1) · Ruth Guinsburg (1) · Terdphong Triratana, DDS (1)
PMID 27093773, PMID 19948613, PMID 26437498, PMID 31164116, PMID 31352795, PMID 32216778